Clinical Trials Browser

Phase 2 × Gliosarcoma × Sorafenib × Clear all

NCT00621686 2018-05-08

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2 Completed

54 enrolled 8 charts

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00597493 2013-06-24

Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM

Phase 2 Completed

32 enrolled 9 charts

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma